Health Care & Life Sciences » Pharmaceuticals | Dong Wha Pharm Co. Ltd.

Dong Wha Pharm Co. Ltd. | Income Statement

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
220,241
213,472
223,201
237,471
258,882
306,603
Cost of Goods Sold (COGS) incl. D&A
127,592
121,267
128,972
136,531
152,969
194,178
Gross Income
92,648
92,205
94,230
100,940
105,913
112,425
SG&A Expense
90,597
85,468
87,809
88,376
93,528
99,624
EBIT
632
4,985
4,417
10,845
10,447
11,229
Unusual Expense
27
-
-
556
3
427
Non Operating Income/Expense
447
262
470
24,067
53,385
446
Interest Expense
384
232
137
8
-
-
Pretax Income
329
5,388
5,537
35,205
65,219
14,539
Income Tax
122
465
392
9,401
18,210
4,471
Equity in Affiliates
561
13
464
450
-
-
Consolidated Net Income
1,012
4,937
5,609
26,254
47,009
10,068
Net Income
1,012
4,937
5,609
26,254
47,009
10,069
Net Income After Extraordinaries
1,012
4,937
5,609
26,254
47,009
10,069
Net Income Available to Common
1,012
4,937
5,609
26,254
47,009
10,069
EPS (Basic)
36.00
177.00
202.00
949.00
1,700.00
364.70
Basic Shares Outstanding
28
28
28
28
28
28
EPS (Diluted)
36.23
176.76
202.40
949.02
1,700.41
364.70
Diluted Shares Outstanding
28
28
28
28
28
28
EBITDA
11,900
17,622
16,282
23,003
21,948
22,586
Other Operating Expense
2,684
1,752
2,003
1,719
1,938
1,571
Non-Operating Interest Income
926
896
786
857
1,167
2,117
Equity in Affiliates (Pretax)
-
-
-
-
217
321

About Dong Wha Pharm Co.

View Profile
Address
19th Floor, STX Namsan Tower
Seoul SL 04637
Korea, Republic Of
Employees -
Website http://www.dong-wha.co.kr
Updated 07/08/2019
Dong Wha Pharm Co., Ltd. engages in the manufacture and sale of pharmaceuticals and medicinal chemicals. Its products include medicines for digesting, skin scars, general cold, gum treatment, high blood pressure, infection, controlling gastrointestinal tract, and others. The company was founded on September 25, 1897 and is headquartered in Seoul, South Korea.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.